1. Home
  2. ACVA vs SDGR Comparison

ACVA vs SDGR Comparison

Compare ACVA & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ACV Auctions Inc.

ACVA

ACV Auctions Inc.

HOLD

Current Price

$4.14

Market Cap

870.4M

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$11.00

Market Cap

854.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACVA
SDGR
Founded
2014
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
870.4M
854.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
ACVA
SDGR
Price
$4.14
$11.00
Analyst Decision
Buy
Buy
Analyst Count
13
8
Target Price
$12.04
$21.13
AVG Volume (30 Days)
2.6M
1.1M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
18.75
45.14
EPS
N/A
N/A
Revenue
$759,606,000.00
$255,869,000.00
Revenue This Year
$13.99
$1.20
Revenue Next Year
$12.62
$4.36
P/E Ratio
N/A
N/A
Revenue Growth
19.22
23.29
52 Week Low
$4.24
$11.11
52 Week High
$17.16
$27.63

Technical Indicators

Market Signals
Indicator
ACVA
SDGR
Relative Strength Index (RSI) 27.55 33.76
Support Level N/A N/A
Resistance Level $5.67 $13.36
Average True Range (ATR) 0.28 0.51
MACD 0.02 -0.05
Stochastic Oscillator 5.67 3.54

Price Performance

Historical Comparison
ACVA
SDGR

About ACVA ACV Auctions Inc.

ACV Auctions Inc operates a mobile platform for wholesale car auctions. It provides a digital marketplace for wholesale vehicle transactions and data services that offer transparent and accurate vehicle information for customers. Additionally, the company's marketplace platform is supported by remarketing centers in various locations throughout the United States.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: